Massey’s bone marrow transplant unit receives Beacon Award for Excellence
The inpatient bone marrow transplant (BMT) unit at VCU Massey Cancer Center is the first of its kind in the nation to earn the American Association of Critical-Care Nurses (AACN) Beacon Award for Excellence. A BMT is a procedure that replaces damaged or destroyed bone marrow with healthy bone marrow stem cells in the treatment of blood cancers like leukemia and lymphoma and other blood and immune disorders. The AACN Beacon Award for Excellence recognizes individual units that distinguish themselves by improving every facet of patient care.
Novel gene target shows promise for bladder cancer detection and treatment
Scientists from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression. The study, published in the journal Clinical Cancer Research, was a collaborative effort between Paul B. Fisher, M.Ph., Ph.D., who originally discovered the mda-9/syntenin gene, and Santanu Dasgupta, Ph.D., an expert in bladder cancer research.
Massey rated the top cancer center in Virginia by U.S. News two years in a row
For the second year in a row, Virginia Commonwealth University Massey Cancer Center was rated the top hospital in Virginia providing high-performing cancer care in U.S. News & World Report’s annual Best Hospitals list. Massey received the highest score in cancer care of the 20 Virginia cancer providers that made the list. VCU Medical Center, which includes Massey’s oncology patient care, also established itself as a No. 1 hospital overall in Virginia for a second consecutive year. It saw two specialty areas rank in the top 50 in the nation, nephrology at 41 and orthopedics in the No. 39 spot.
New Massey Research Pavilion fosters collaboration among cancer researchers
A new hub for cancer research known as the Massey Research Pavilion opened in April 2013 in the VCU School of Medicine’s McGlothlin Medical Education Center, a new 12-story, 200,000-square-foot, state-of-the-art building. The Massey Research Pavilion—located on floors 11 and 12—provides 27,000-square-feet of dedicated space for VCU Massey Cancer Center’s clinical trials research, cancer prevention and control research and Division of Hematology, Oncology and Palliative Care chair, Steven Grossman, M.D., Ph.D., and his administrators. Each floor is appointed with a suite of research offices and conference rooms.
Khalid Matin named medical director of community oncology and clinical research affiliations
Khalid Matin, M.D., F.A.C.P., has been appointed medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the VCU School of Medicine, effective July 15, 2013.